In Vivo Efficacy of the New Ketolide Telithromycin (HMR 3647) in Murine Infection Models

We compared the oral antibacterial activities of telithromycin (HMR 3647), a new ketolide drug, in different infections induced in mice by Staphylococcus aureus, Streptococcus pneumoniae, streptococci, enterococci, and Haemophilus influenzae with those of various macrolides and pristinamycin. Unlike...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bonnefoy, Alain, Guitton, Michele, Delachaume, Carole, Le Priol, Pascal, Girard, Anne-Marie
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2001
Schlagworte:
Experimental Therapeutics
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC90532/
https://ncbi.nlm.nih.gov/pubmed/11353612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.6.1688-1692.2001
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge